Browse Pet Safety Reports
18,010 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 18,010 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product — widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 18,010 FDA veterinary adverse event reports for Horse.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Jul 15, 2024 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Jul 15, 2024 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Jul 15, 2024 | Horse | Horse (unknown) | Pergolide Mesylate | Partial anorexia | Recovered/Normal |
| Jul 15, 2024 | Horse | Horse (unknown) | Detomidine Hydrochloride | Hives (see also Skin); Underdose | Recovered/Normal |
| Jul 13, 2024 | Horse | Horse (unknown) | Detomidine Hydrochloride | Lethargy (see also Central nervous system depression in Neurological); Inject... | Recovered/Normal |
| Jul 12, 2024 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Jul 12, 2024 | Horse | Unknown | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Jul 10, 2024 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Recovered/Normal |
| Jul 10, 2024 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Jul 10, 2024 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Recovered/Normal |
| Jul 10, 2024 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Jul 9, 2024 | Horse | Warmblood (unspecified) | Firocoxib | Reluctant to move; Bone and joint disorder NOS; Tachycardia; Abnormal digital... | Outcome Unknown |
| Jul 9, 2024 | Horse | Hanovarian | Flunixin Meglumine Oral Paste | Lymph node abscess | Outcome Unknown |
| Jul 9, 2024 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Jul 9, 2024 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Jul 9, 2024 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Recovered/Normal |
| Jul 8, 2024 | Horse | Warmblood (unspecified) | Betavet | Joint effusion; Cellulitis | Outcome Unknown |
| Jul 8, 2024 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Recovered/Normal |
| Jul 5, 2024 | Horse | Thoroughbred | Betavet | Joint effusion; Lameness; Death by euthanasia | Euthanized |
| Jul 4, 2024 | Horse | Unknown | Firocoxib | Elevated aspartate aminotransferase (AST); Elevated gamma-glutamyl transferas... | Outcome Unknown |
| Jul 3, 2024 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Jul 3, 2024 | Horse | Quarter Horse | Pergolide Mesylate | Not eating | Recovered/Normal |
| Jul 3, 2024 | Horse | Unknown | Omeprazole | Lack of efficacy - NOS | Recovered/Normal |
| Jul 3, 2024 | Horse | Warmblood (unspecified) | Omeprazole | Lack of efficacy - NOS | Recovered/Normal |
| Jul 2, 2024 | Horse | Quarter Horse | Ivermectin; Praziquantel | Injection site swelling; Rolling; Hard stool; Gut sounds decreased | Outcome Unknown |
| Jul 1, 2024 | Horse | Unknown | Ivermectin; Praziquantel | Oral swelling; Abnormal rectal palpation | Outcome Unknown |
| Jul 1, 2024 | Horse | Tennessee Walking Horse | Pergolide Mesylate | Anorexia; Diarrhoea; Hypoproteinaemia | Recovered/Normal |
| Jul 1, 2024 | Horse | Horse (unknown) | Pergolide Mesylate | Food refusal; Lethargy (see also Central nervous system depression in Neurolo... | Outcome Unknown |
| Jul 1, 2024 | Horse | Unknown | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Jul 1, 2024 | Horse | Horse (unknown) | Pergolide Mesylate | High adrenocorticotropic (ACTH) hormone; Localised hair loss | Outcome Unknown |
| Jul 1, 2024 | Horse | Quarter Horse | Furosemide Injection | Injection site swelling; Injection site warmth; Injection site pain; Fever; O... | Ongoing |
| Jul 1, 2024 | Horse | Horse (unknown) | Ketamine Hydrochloride | Lack of efficacy - NOS | Recovered/Normal |
| Jul 1, 2024 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Recovered/Normal |
| Jul 1, 2024 | Horse | Quarter Horse | Firocoxib | Hives (see also Skin) | Recovered/Normal |
| Jul 1, 2024 | Horse | Welsh Cob | Detomidine Hydrochloride | Death by euthanasia; Seizure NOS; Fracture; Falling; Elevated liver enzymes N... | Euthanized |
| Jun 30, 2024 | Horse | Warmblood (unspecified) | Ceftiofur Crystalline Free Acid | Heavy sweating; Trembling; Collapse NOS (see also Cardio-vascular and Neurolo... | Recovered/Normal |
| Jun 30, 2024 | Horse | Horse (unknown) | Ivermectin; Praziquantel | Angioedema | Outcome Unknown |
| Jun 30, 2024 | Horse | Warmblood (unspecified) | Polysulfated Glycosaminoglycan | Injection site hair loss | Outcome Unknown |
| Jun 29, 2024 | Horse | Quarter Horse | N-Butylscopolaminium Bromide | Diarrhoea; Elevated renal parameters; Increased packed cell volume (PCV) | Recovered/Normal |
| Jun 29, 2024 | Horse | Quarter Horse | Flunixin Meglumine Injectable | Diarrhoea; Elevated renal parameters; Increased packed cell volume (PCV); Inf... | Ongoing |
| Jun 28, 2024 | Horse | Quarter Horse | Xylazine Hydrochloride | Lack of efficacy - NOS; Intentional misuse | Outcome Unknown |
| Jun 28, 2024 | Horse | Quarter Horse | Ketamine Hydrochloride | Lack of efficacy - NOS; Intentional misuse | Recovered/Normal |
| Jun 27, 2024 | Horse | Mustang | Detomidine Hydrochloride | Sedation prolonged; Behavioural disorder NOS | Outcome Unknown |
| Jun 27, 2024 | Horse | Quarter Horse | Pentosan Polysulfate Sodium | Injection site swelling; Muscle stiffness | Outcome Unknown |
| Jun 26, 2024 | Horse | Mustang | Omeprazole | INEFFECTIVE, GASTRIC ULCER(S); Inappropriate schedule of drug administration | Outcome Unknown |
| Jun 26, 2024 | Horse | Arab | Pergolide Mesylate | Colic | Outcome Unknown |
| Jun 26, 2024 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Jun 25, 2024 | Horse | Percheron | Florfenicol Inj Sol 30% W Pg | Injection site swelling | Ongoing |
| Jun 25, 2024 | Horse | Paint | Ceftiofur Crystalline Free Acid | Colic; Injection site tenderness | Recovered/Normal |
| Jun 25, 2024 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe — difficulty breathing, seizures, collapse, or severe swelling — seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.